BridgeBio Pharma, Inc.

BBIONASDAQHealthcare● Active

$67.61

+$0.28(+0.42%)

Market Cap$13.2B

P/E Ratio—

52W High$84.94

52W Low$37.69

Avg Volume2.6M

Open$67.45

Beta0.97

Cash on Hand Financials Revenue

BridgeBio Pharma, Inc. (BBIO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BBIO · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$587.5M▼ -13.7% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$570.1M

cashAndCashEquivalents

Short-Term Investments

$17.4M

shortTermInvestments

YoY Change vs Prior Year

-13.7%

vs prior fiscal year

Latest Quarter

$940.2M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$587.5MCash on Hand

Total Debt$2.73BTotal Debt

Net Cash / Net Debt−$2.14BNet Debt Position

Cash vs Debt Ratio

Cash 18%BridgeBio Pharma, Inc. cash as % of market cap: 4.44%% · MCap $13BDebt 82%

BridgeBio Pharma, Inc. carries a net debt position of $2.14B. Total debt ($2.73B) exceeds cash on hand ($587.5M). BridgeBio Pharma, Inc. cash vs debt ratio: 18% cash / 82% debt.

Net Cash = Cash & ST Investments − Total Debt$587.5M − $2.73B = −$2.14B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

BBIO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

BBIO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$587.5M-13.7%

Dec 31, 2024FY$681.1M+56.6%

Dec 31, 2023FY$434.9M-7.8%

Dec 31, 2022FY$471.9M-43.6%

Dec 31, 2021FY$836.7M+37.8%

BBIO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

BBIO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

BridgeBio Pharma, Inc.YOU

BBIO

$587.5M$13B4.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

BridgeBio Pharma, Inc. (BBIO) cash on hand as of December 31, 2025 is $587.5M, comprising $570.1M in cash and cash equivalents (CCE) plus $17.4M in short-term investments — reported as BridgeBio Pharma, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as BridgeBio Pharma, Inc. cash reserves or cash position.

BridgeBio Pharma, Inc. annual cash on hand history shows decreased -13.7% in 2025: decreased -13.7% in 2025. BridgeBio Pharma, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

BridgeBio Pharma, Inc. carries total debt of $2.73B against cash of $587.5M, resulting in a net debt position of -$2.14B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

BBIO cash on hand · 5 questions

As of December 31, 2025, BridgeBio Pharma, Inc. (BBIO) has $587,482,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $570,119,000 in cash and cash equivalents (CCE) plus $17,363,000 in short-term investments. Latest quarter (March 31, 2026): $940,186,000. Data sourced from the annual 10-K filing via FMP.

BBIO cash on handBBIO cash reservesBBIO cash 2025how much cash does BBIO have

▸ Source: FMP /balance-sheet-statement · US GAAP · BridgeBio Pharma, Inc. · BridgeBio Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025